1. Home
  2. NVNI vs LUMO Comparison

NVNI vs LUMO Comparison

Compare NVNI & LUMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVNI
  • LUMO
  • Stock Information
  • Founded
  • NVNI 2019
  • LUMO 2011
  • Country
  • NVNI Brazil
  • LUMO United States
  • Employees
  • NVNI N/A
  • LUMO N/A
  • Industry
  • NVNI
  • LUMO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVNI
  • LUMO Health Care
  • Exchange
  • NVNI Nasdaq
  • LUMO Nasdaq
  • Market Cap
  • NVNI 42.9M
  • LUMO 37.7M
  • IPO Year
  • NVNI N/A
  • LUMO N/A
  • Fundamental
  • Price
  • NVNI $0.93
  • LUMO $4.33
  • Analyst Decision
  • NVNI Strong Buy
  • LUMO Buy
  • Analyst Count
  • NVNI 1
  • LUMO 4
  • Target Price
  • NVNI $5.00
  • LUMO $9.38
  • AVG Volume (30 Days)
  • NVNI 11.0K
  • LUMO 130.8K
  • Earning Date
  • NVNI 11-26-2024
  • LUMO 11-07-2024
  • Dividend Yield
  • NVNI N/A
  • LUMO N/A
  • EPS Growth
  • NVNI N/A
  • LUMO N/A
  • EPS
  • NVNI N/A
  • LUMO N/A
  • Revenue
  • NVNI $23,558,620.00
  • LUMO $2,205,000.00
  • Revenue This Year
  • NVNI $25.91
  • LUMO $184.11
  • Revenue Next Year
  • NVNI $17.52
  • LUMO N/A
  • P/E Ratio
  • NVNI N/A
  • LUMO N/A
  • Revenue Growth
  • NVNI 38.59
  • LUMO 300.59
  • 52 Week Low
  • NVNI $0.58
  • LUMO $1.37
  • 52 Week High
  • NVNI $3.20
  • LUMO $4.58
  • Technical
  • Relative Strength Index (RSI)
  • NVNI 52.17
  • LUMO 56.58
  • Support Level
  • NVNI $0.75
  • LUMO $4.25
  • Resistance Level
  • NVNI $1.12
  • LUMO $4.44
  • Average True Range (ATR)
  • NVNI 0.14
  • LUMO 0.11
  • MACD
  • NVNI 0.01
  • LUMO -0.03
  • Stochastic Oscillator
  • NVNI 43.04
  • LUMO 33.33

About NVNI Nvni Group Limited

Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.

About LUMO Lumos Pharma Inc.

Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.

Share on Social Networks: